Oropharyngeal cancer: what is the best chemotherapy strategy?
Access to the full content of this site is available only to registered healthcare professionals.
Register to read more
- Curative-dose radiotherapy/induction chemotherapy (IC) had similar survival benefits as concurrent chemotherapy (CRT) for patients with locally advanced oropharyngeal carcinoma (OPSCC).
- CRT and IC were associated with similar 5-year overall survival results in multivariate analysis (HR 0.95, p=.255).
- CRT was associated with significantly improved overall survival compared with IC for patients with HPV-negative, high-risk OPSCC (HR 0.63, p=.0...